Journal Article

Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections

Hervé Zylberberg and Stanislas Pol

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 23, issue 5, pages 1117-1125
Published in print November 1996 | ISSN: 1058-4838
Published online November 1996 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1093/clinids/23.5.1117
Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) share the same routes of transmission, which explains the high rate of HCV and HIV coinfection (∽9%). HIV/HCV coinfection leads to high rates of indeterminate recombinant immunoblot assay patterns and seroreversion; high levels of viral replication; and a more severe histopathologic course. By contrast, HCV infection does not seem to accelerate the progression of HIV infection. Interferon α (IFN-α) in coinfected patients leads to a similar rate of primary responses, but sustained responses are less frequent. The potential severity of hepatitis C virus infection evidences the need for early diagnosis. Liver biopsy should be performed for all HCV RNA-positive patients in order to evaluate the activity of the liver disease. Given the poor efficiency of IFN-α in terms of sustained response in HIV-infected patients, reinforced therapeutic procedures (long-term administration of IFN-α or combined ribavirin/IFN-α) should be proposed, at least for those patients with severe liver disease.

Journal Article.  0 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.